<DOC>
	<DOCNO>NCT01562574</DOCNO>
	<brief_summary>This trial conduct Oceania . The aim trial investigate efficacy activate recombinant human factor VII standard treatment compare standard haemostatic replacement therapy cardiopulmonary bypass ( CPB ) surgery paediatric congenital heart disease .</brief_summary>
	<brief_title>Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery Paediatric Congenital Heart Disease</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Signed informed consent obtain parent legal guardian trialrelated activity . Trialrelated activity procedure would perform normal management subject Children complex congenital heart disease require corrective surgery cardiopulmonary bypass ( CPB ) Congenital heart disease require CPB surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>